Commercial Perspectives in Biotechnologies
A UK based Private Equity firm was looking to invest in a biotechnology company in the US, which had patented a new molecule to treat a very widely spread stomach condition. They wanted to assess the commercial viability of this new product and the potential threat from competition.
LB Networks organised a series of 15 calls with both senior individuals with relevant biotech experience and doctors, including:
Ex Senior Vice President Business Development at a comparable player in the market.
Ex Head of Sales at a leading pharmaceutical company.
Several doctors specialised in gastric diseases.
Our client was able to build an opinion on:
The Go-to-Market strategy to adopt versus similar products.
The risks linked to potential competition.
The growth perspectives based on practitioners feedback.